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Abstract: Human Papillomavirus infections (HPV) are the 
most common sexually transmitted diseases in the United 
States. Of cancers in parts of the body where HPV is often 
discovered about 80% originated from an HPV infection. 
Despite this knowledge and the effectiveness of the HPV 
vaccine, vaccination by both genders in Kentucky and on 
a national scale remains highly underutilized. As a result, 
preventable incidence and mortality rates from HPV-related 
illness are elevated. Health care delivery factors such as 
increased vaccination and preventative care, insurance 
coverage, and accessible rural health care are necessary 
for HPV prevention and promotion of holistic health. 
The importance of advocacy for policies supporting the 
vaccine, sexual health, and education about HPV and the 
vaccine is fundamental to reducing HPV-related cancer 
rates nationwide. Since the vaccine was approved in 2006, 
education in forms of parental endorsement, healthcare 
provider recommendation, peer support, and video 
intervention have proven effective. As time passes and the 
vaccine is increasingly utilized, there will be an opportunity 
for research to identify methods of education for specific 
populations.
Keywords: Human Papillomavirus, HPV, Prevention, 
Vaccine, Vaccination, Occupational Science, OS, 
Occupational Therapy, OT
Description of Human Papillomavirus and Vaccination
 Human Papillomavirus infections (HPV) are the most common 
sexually transmitted diseases in the United States. Human Papillomavirus 
is contracted through skin and mucous membrane contact of an infected 
individual with another. The contact does not require penetrative sexual 
intercourse, thus can be passed on to others by various forms of sexual 
activity. Some sexually transmitted forms of HPV are low-risk and others are 
high-risk. Low-risk forms of HPV do not cause cancer, yet are responsible 
for 90% of all cases of genital warts (National Cancer Institute, 2015). 
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High-risk forms of HPV can lead to the development of cervical cancer, 
anal cancer, oropharyngeal cancers, and cancers of the vagina, vulva, and 
penis. Although most high-risk HPV infections will be resolved by the 
body’s immune system, 70% of all cervical cancers are caused by two 
high-risk HPV strains alone (National Cancer Institute, 2015). The Food 
and Drug Administration has approved the use of three vaccines to prevent 
HPV, Gardasil being the most common. These vaccinations eliminate HPV 
strains 16 and 18, the strains responsible for 70% of all cervical cancer 
diagnoses (National Cancer Institute, 2015). Because these vaccinations 
do not combat HPV infections or HPV-induced cancers that already exist, 
preventative vaccination is imperative.
National and Community Health Care Issues
 Nationwide, four out of ten adolescent girls and six out of ten 
adolescent boys have not received the HPV vaccine (Centers for Disease 
Control and Prevention [CDC], 2015). Not only is this alarming on a 
national scale, but Kentucky faces additional risk. Compared to other 
states, Appalachian Kentucky shows significantly higher rates of diagnoses 
and deaths as a result of HPV-related cancers (Wilburn, Vanderpool, 
Knight, Evers, n.d.). Despite the disturbing rates of HPV-related cancers in 
Kentucky, HPV vaccine utilization is low. Only 26.8% of adolescent girls 
(ages 13-17) have received all three doses of the HPV vaccine, compared 
to the national rate of 37.6% (CDC, 2014). Data for Kentucky males, ages 
13-17, is incomplete beyond 19% initiating the series, significantly lower 
than the 35% U.S. male initiation rate (CDC, 2014). Because of low HPV 
vaccination rates both nationally and in Kentucky, issues of education and 
prevention must be addressed.
How HPV Prevention Impacts the Delivery of Health Care
 This topic impacts the delivery of health care because several factors 
must be recognized for cost-efficient, accessible HPV prevention. The funds 
required to provide HPV vaccines for higher percentages of the population 
and to increase Papanicolaou tests (also referred to as pap tests, or cervical 
screenings for HPV or cancerous cells) must be available and used in the 
most efficient way to deliver these services and remain effective. In addition, 
healthcare coverage providing access to preventative care to cover these 
costs is essential. There must also be primary care physicians accessible 
to young people in order for them to receive pap tests and vaccination. 
“More than two-thirds of Kentucky’s counties – 81 out of 120, and nearly 
all of them rural – are officially designated health professional shortage 
areas (HPSAs) for primary care by the Health Resources and Services 
Administration” (Casey, Jones, Gross, & Dixon, 2004, p. 3). Because 
primary care providers are typically who administer these crucial services, 
this shortage is a relevant obstacle in Kentucky and other rural parts of the 
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country to adequate care for cervical screening and vaccination. One study 
involved focus groups with 27 women, 19 parents, 31 community leaders, 
and 37 healthcare providers in Appalachian Ohio. These participants 
revealed that central barriers to HPV vaccination in this region are access 
to healthcare services, access to insurance coverage, poor patient-provider 
communication, and insufficient time (Katz, Reiter, Heaner, Ruffin, Post, 
D. M., & Paskett, E. D., 2009). Not only does Ohio neighbor Kentucky 
directly, but because these regions are both Appalachian, they also share the 
same rural qualities. Thus, these issues regarding health care delivery must 
be addressed in order to effectively protect individuals from HPV infections 
in rural regions of the United States. 
Impact of HPV and Prevention on Population
 Although HPV infections and HPV-related cancers affect 
individuals of all ages, HPV prevention and vaccination is concentrated 
on young people. Pichichero (2007) discussed the Gardasil vaccine after 
its development and release, explaining that pre-adolescent and adolescent 
girls were the primary target recipients of the vaccine. Ages 11 through 12 
were the initial focus for Gardasil, but the Food and Drug Administration 
approved the use of the vaccine in females as young as nine. This age range 
is critical because they are unlikely to have yet engaged in sexual activity 
putting them at risk for HPV infection. Although this age range is ideal, 
women are encouraged to receive the vaccine through age 26. “Vaccination 
of the entire US population of 12-year-old girls would prevent more than 
200,000 HPV infections, 100,000 abnormal Pap tests, and 3,300 cases of 
cervical cancer” (Pichichero, 2007, p. 197). The remarkable positive effects 
of vaccination on women are apparent, but for men, are often overlooked. 
Because the vaccine is frequently marketed for preventing cervical cancer, 
many are unaware that HPV vaccination in men can also prevent “more 
than 5 million cases of genital warts and 40,000 cancer-related deaths over 
the next century” (Thomas & Snell, 2013). Thus, our national population is 
eventually affected because HPV prevention has the ability to decrease the 
rates of HPV-related cancers in both males and females of future generations. 
 Of cancers in parts of the body where HPV is often discovered, 
approximately 80% of them are caused by HPV infections (CDC, 2016). 
Despite this knowledge, HPV vaccination by both genders remains 
underutilized. Education about HPV and the vaccine must be emphasized 
in order to reduce HPV-related cancer rates nationwide.
Healthcare Policy and Primary Care in Relation to HPV Prevention
 Human Papillomavirus prevention is promoted through the 
Affordable Care Act (ACA) in multiple ways. The ACA expands Medicaid 
coverage, providing more accessibility to the HPV vaccination and pap tests. 
Preventative care is now also covered under the ACA, promoting services
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to avoid HPV infection. According to one study, the ACA was found to 
be associated with an estimated 1.1 million more women (ages 19 to 25) 
initiating the HPV vaccination series and 854,000 more completing it than 
prior to its implementation (Lipton & Decker, 2015). Healthy People 2020, 
a national initiative that has set objectives to improve the overall health of 
the United States by year 2020, also promotes increasing HPV vaccination 
rates. Kentucky has set a goal to have 80% of adolescents immunized against 
HPV by 2020 to align with these national goals (Wilburn, Vanderpool, 
Knight, Evers, n.d.).  
 Primary care is intended to be the initial contact an individual has with 
health care delivery services. Its goal is to be comprehensive, coordinated, 
and consistent (Shi & Singh, 2015). Consistency of primary care is essential 
to HPV prevention because pap tests and HPV screening are recommended 
every three years. If an individual has a history of abnormal pap results they 
should consult with their primary care provider to have more frequent pap 
tests and ensure that cervical cancer does not develop (American Society 
of Cytopathology, 2016). In addition, having a primary care provider is 
central to HPV prevention because individuals must see their provider on 
three occasions in order to receive all three doses before the vaccine will 
take effect. After the first dose, the second administration should occur 
at least 1 to 2 months later. The third dose should be received 6 months 
after the first (Immunization Action Coalition, 2016). If an individual lacks 
consistent primary care, this increases the barrier to completing the series 
and protecting themselves against infection.
Application of HPV Prevention to Occupational Science
 Occupational science places emphasis on promoting the physical, 
mental, social, and spiritual health of individuals, otherwise known as 
holistic health (Shi & Singh, 2015). In contrast, the United States has 
historically focused on the medical model of health care, which emphasizes 
making a diagnosis and treating that issue. After treatment, the person is 
then considered “healthy”. As a result, many Americans only see physicians 
when they feel ill. In order to promote HPV prevention, society’s ideas of 
health and healthcare delivery must shift away from the medical model’s 
emphasis on diagnosis and toward preventative care. This encourages 
individuals to see physicians in order to address all aspects of their health 
periodically to prevent illness. HPV vaccination and screening lie within 
these periodic visits, preventing HPV-related cancers rather than treating 
the person after a cancer diagnosis has been made.  
 In addition to holistic health, occupational science stresses 
recognizing the individual cultural beliefs and values of clients and 
understanding how they influence occupational behavior. Hasselkus (2011) 
explains that culture influences what occupations are chosen for routines, 
priorities, and what daily behaviors are considered suitable according to 
their values. Therefore, culture may influence what preventative care and
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medical services an individual is willing to consider. For example, a study 
assessing HPV vaccination in Appalachia found that states in the U.S. “Bible 
Belt” have values that affect their utilization of the vaccine. Individuals with 
more conservative and religious beliefs were less likely to accept or receive 
the vaccine (Reiter, Katz, & Paskett, 2013). Because occupational science 
emphasizes understanding how values influence occupation, political and 
religious principles are important factors to consider when encouraging 
HPV preventative care in Kentucky.
HPV Prevention and Role as a Future Healthcare Provider
 The goal of promoting and utilizing preventative care is that the 
future of healthcare delivery will shift toward focusing on the preventative 
needs of our nation and community, resulting in a healthier population 
overall. As a healthcare provider, advocating for HPV prevention and 
educating others about its importance is essential. A healthcare provider 
should be committed to all aspects of their client’s physical, mental, social, 
and spiritual wellness. Therefore, the provider does not need to be a primary 
care physician or gynecologist to promote sexual and reproductive health. 
Working in pediatric care is an opportunity to educate adolescent clients and 
their parents about HPV and vaccination through pamphlets, videos, or open 
discussions about sexual health. Healthcare providers can also recommend 
clients to see other professionals to learn more. In order to provide clients 
with knowledge about these topics, providers have a responsibility to be 
educated about the seriousness of sexual health issues in young people. 
 In addition to client education, healthcare providers can engage 
in legislative advocacy to address HPV-related issues and promote 
preventative care. For example, in 2006, Representative Watkins sponsored 
a bill in Kentucky to require HPV vaccination for school enrollment. 
Despite amending the bill the following February by offering parents the 
ability to opt out of the vaccine for any reason, the bill did not pass (Dekker, 
2008). Healthcare providers can meet with state legislators to advocate for 
the passage of such bills by providing them with knowledge of HPV and 
cervical cancer rates and the cost-effective nature of preventative care. They 
can also educate others about the issues and form advocacy groups willing 
to speak to legislators together. 
Relevance of HPV Prevention to Current Healthcare Policies
 Controversy still surrounds the HPV vaccine due to distrust of 
pharmaceutical companies, the cost of the vaccination series, debate 
surrounding adolescent prevention of sexually transmitted infections 
(stressing abstinence-only approaches), and fear of side effects of the 
vaccine (Larkin, 2007). These conflicting viewpoints have had significant 
influence on healthcare policy surrounding the vaccine.
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In an attempt to promote HPV vaccination, many state legislators have 
proposed mandating them, much like Representative Watkins’s bill in 2007. 
Such a bill was proposed again in Kentucky in 2014 and rejected. The 
most recent bill was proposed in February of 2015, encouraging Kentucky 
citizens to educate themselves about HPV-related cancers and advantages of 
receiving the vaccine. Only Virginia, Washington, D.C., and Rhode Island 
currently have laws in place mandating the vaccine (National Conference 
of State Legislatures, 2016). These bills have yet to pass in most states due 
to the controversial nature of the issue and illustrate how political climate 
influences healthcare policy. 
 In addition to political barriers, other policy issues regarding 
administrative protocol within clinics affect HPV vaccination rates. In a 
study asking healthcare providers (7 nurses and 1 physician) in Appalachian 
Kentucky about low HPV vaccine uptake, they recommended several policy 
changes that would increase the likelihood of individuals receiving the 
vaccine. These changes altered interactions with women during their health 
care experience, such as asking about their HPV vaccination status upon 
arrival, having a standing physician order for the vaccine, and asking about 
the vaccine during women’s health appointments and college physicals 
(Head, Vanderpool, & Mills, 2013). This illustrates how minor policy 
changes outside of larger legislative decisions can also have an impact on 
vaccination rates. 
Implications of HPV Prevention on Healthcare Service Delivery
 Education is a pivotal factor in promoting HPV preventative 
behaviors. Education for the general public about HPV, the many cancers 
predominantly caused by HPV infections, and characteristics of the 
vaccine is fundamental to increasing vaccination rates and dispelling myths 
about its safety and effectiveness. Research analyzing what methods are 
most effective for promoting HPV vaccines in women can be utilized to 
encourage receiving the vaccine. A study of 495 women ages 18 to 26 
in southeastern Kentucky showed that parental endorsement, healthcare 
provider recommendation, and peer support all enhanced the probability of 
receiving the vaccine (Casey, Crosby, Vanderpool, Dignan, & Bates, 2013). 
Another study revealed that an intervention titled “1-2-3 Pap” utilizing a 
DVD about HPV vaccination and cervical cancer made women 2.44 times 
more likely to complete the vaccination series (Vanderpool, Cohen, Crosby, 
Jones, Bates, Casey, & Collins, 2013). Based on evidence, these methods 
are useful to health promotion programs attempting to increase rates of 
those receiving the vaccine because they are applicable to many populations 
and involve education at multiple levels (family, health care delivery, and 
peers).
 Humpan Papillomavirus vaccination and promotion have historically 
been targeted toward women. Because there is currently no test for males to 
indicate if they carry HPV, future delivery should also emphasize the
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positive effects of males receiving the vaccine as well. A study analyzing 
parents’ decisions about HPV vaccination found that 76% of decisions to 
vaccinate sons were likely or very likely influenced by protecting their 
female partners from HPV transmission (Schuler, DeSousa, & Coyne-
Beasley, 2014). Parents of adolescent males may be unaware that their sons 
can unknowingly be carriers of HPV. This study suggests that educating 
parents of males about the harmful implications of not receiving the vaccine 
on females may increase vaccination rates. 
Consequence of HPV Prevention on Healthcare Service Delivery
 Education about the seriousness of HPV infections and the 
effectiveness of the HPV vaccine will increase the probability of adolescents 
and their parents being receptive to considering the vaccine. As a result, 
rates of those receiving the vaccine will increase, thus reducing the amount 
of HPV-related cancers in Kentucky and the rest of the country. Because the 
FDA recently approved the HPV vaccine in 2006 and there has been limited 
success in its utilization, research has yet to discover what methods of 
education are most effective. As time passes, there will be opportunities for 
research to discover what methods are proving most valuable in educating 
diverse populations about HPV and the vaccine to increase its use.    
Because cost of healthcare delivery is a primary concern in the United 
States, cost of HPV prevention should be addressed. Research suggests 
that preventative care in the form of pap screens and HPV vaccination will 
save the government sizeable funds. One study analyzed the costs of family 
planning compared to costs of treating preventable conditions. The study 
revealed that in 2010 pap tests and HPV vaccination prevented about 3,680 
cases of cervical cancer, 2,110 cervical cancer deaths, and 9,000 cases of 
abnormal sequelae and precancerous lesions. As a result, the government 
saved 23 million dollars by performing pap tests and HPV vaccinations 
(Frost, Sonfield, Zolna, & Finer, 2014). Service delivery will be impacted 
because initial costs to distribute and perform vaccines and screenings to 
higher percentages of the population will be costly, yet evidence shows 
that in the long-term money will be saved by utilizing these preventative 
methods. 
Conclusion
 Preventative care is central to improving overall health. By promoting 
HPV vaccination and pap tests, the amount of HPV-related cancers will be 
reduced nationwide. Increasing HPV vaccination rates is a multidimensional 
process involving recognition of access to services, cost of vaccination and 
screening, client education about HPV and cervical cancer, and how culture 
influences acceptability of HPV preventative care. 
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